Skip Navigation

Advertise|Press|Contact|FAQ|About Us

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Oncology | Pulmonary/Respiratory Diseases | Family Medicine
Disease Category: Non-Small Cell Lung Cancer
Location: United States, ND

Clinical Trial Details

Overview

Research Study Summary

Non-Small Cell Lung Cancer

Purpose

First-line treatment for patients with non-squamous non-small cell lung cancer

Patient Inclusion Criteria:

  • Confirmed diagnosis, at least one measurable target lesion, 18+ years of age, life expectancy of >12 weeks

Patient Exclusion Criteria:

  • Small cell or carcinoid lung cancer patients are ineligible, untreated brain metastases, history of active malignancy in the past 3 years

To Learn more
Phase

2

Gender

Both Male and Female

Age

18 and up

Overall Status

Recruiting

Facility Type

N/A

Contact

Dr. Tom Davis, Director of Business Development
Legacy Pharma Research
601 N. 5th St.
Bismarck, ND 58501
Phone: 701-751-1128
Fax: 701-751-1131

View Map

If you would like to learn more about participating in this research study, please email the trial contact using the form below.

Name:
Address:
City:
State:
Zip/Postal Code:
Country:
Phone:
Email:  
Message:
 
Please leave this field empty.

CW ID: 163095

Date Last Changed: July 24, 2013


DISCLAIMER: CenterWatch does not conduct clinical research. CenterWatch is a publishing company that posts clinical trials information on behalf of sponsor companies, contract research organizations, clinical research sites and other interested parties. This information is designed to help patients find clinical trials of interest and contact the research centers conducting the trials.